AMRX vs DAL · P/E 44, rev $2.79B vs P/E 12, rev $61.64B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the AMRX and DAL stock pages for the full models.
Not investment advice.